However, the evolution of new targets for biologics, such as IL-17 or IL-23, or small molecules targeting intracellular signals, have recently revolutionized the spectrum and goals of psoriasis treatment strategies [1,33]. The gene discussed is IL17A; the disease is psoriasis.